March 14, 2016 12:46 PM
SINGAPORE – A new drug has been approved which has been shown to reduce the risk of cardiovascular death, as well as hospitalisation for patients with chronic heart failure.
New approved drug reduces risk of death from heart conditions compared to 'gold standard'
